Myocardial injury and cardiac dysfunction after traumatic brain injury (TBI) have been
reported in observational studies, but there is no robust estimate of their incidences. We …

Background CKD is common in heart failure (HF) and associated with morbidity and
mortality, yet life-prolonging medications such as renin-angiotensin-aldosterone inhibitors …

Cardiovascular disease (CVD) is the primary cause of morbidity and mortality in chronic
kidney disease (CKD). CVD mortality risk doubles and triples in CKD stages 3 and 4 …

Acute myocardial infarction (AMI) is a prevalent cardiovascular disease associated with high
morbidity and mortality, posing a significant threat to human health. Therefore, early …

Abstract Purpose of Review Propensity of patients with chronic kidney disease (CKD) to
adverse outcomes of acute coronary syndromes (ACS) derives, in part, from imperfection in …

Introduction Hemolytic–uremic syndrome (HUS) can occur as a systemic complication of
infection with Shiga toxin (Stx)-producing Escherichia coli (STEC). Most well-known aspects …

Background: The use of high-sensitive cardiac troponin T (hsTnT) in urine as a marker of
cardiac damage in children has not yet been reported. Elimination of cardiac troponins is …

Abstract Methadone (R, S‐methadone) can prolong the QT interval. R‐methadone inhibits
cardiac potassium channel function less than S‐methadone. We tested if switching from …

Background Elevated cardiac biomarkers, such as high-sensitivity cardiac Troponin T and N-
terminal pro-B-type natriuretic peptide improve the prediction of major adverse cardiac …

Cardiac troponin (Tn) plays a central role in the evaluation of patients with angina
presenting with acute coronary syndrome. The advent of high-sensitivity assays has …